Back
Palo Alto Networks Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
80
PANW
Palo Alto Networks
Last Price:
322.59
Seasonality Move:
9.79%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
80
Palo Alto Networks (PANW)
is a Buy
Is Palo Alto Networks a Buy, Sell or Hold?
- The current Palo Alto Networks [PANW] share price is $322.62. The Score for PANW is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- PANW is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PANW Stock Price Chart
What is Palo Alto Networks's stock price today?
-
The Palo Alto Networks share price today is $322.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PANW is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
PANW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.96 | Buy |
| Relative Strength Index (14 RSI): | 60.33 | Buy |
| Chaikin Money Flow: | 578704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (299.41 - 320.09) | Buy |
| Bollinger Bands (100): | (276.13 - 330.09) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 46.74 | Sell |
| Chaikin Money Flow: | 84619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Sell |
| Bollinger Bands (100): | (40.86 - 48.8) | Sell |
PANW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 318.02 | Buy |
| 20-day SMA: | 308.33 | Buy |
| 50-day SMA: | 301.85 | Buy |
| 200-day SMA: | 288.67 | Buy |
| 8-day EMA: | 317 | Buy |
| 20-day EMA: | 311.94 | Buy |
| 50-day EMA: | 305.25 | Buy |
| 200-day EMA: | 284.93 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.53 | Buy |
| 20-day SMA: | 40.36 | Sell |
| 50-day SMA: | 41.57 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.71 | Buy |
| 20-day EMA: | 40.38 | Sell |
| 50-day EMA: | 41.84 | Sell |
| 200-day EMA: | 43.38 | Sell |
Palo Alto Networks Earnings Growth & PANW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.11 per share, an increase this year of $1.30 per share, and an increase next year of $0.61 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Palo Alto Networks Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||